RIG-101

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameRIG-101
Drug Alias NameRIG-101
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionRetinoic acid-inducible gene I stimulants
TargetsRetinoic acid-inducible gene I
Therapy Area/IndicationsAsthmaRespiratory Tract DiseasesNeoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRIGImmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesRIGImmune Inc
Inactive CompaniesN/A
Active IndicationsAsthmaRespiratory Tract DiseasesNeoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A